Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2013


The 6th (2013) International Bio-pharmaceutical R&D Innovation Asia Summit

27 May 2013 - 29 May 2013 - Shanghai, China



Bookmark and Share


The 6th International Bio-pharmaceutical Industrial Development Innovation Forum & The 6th (2013) International Bio-pharmaceutical R&D Innovation Asia Summit will be held on May.27th-29th, 2012 in Shanghai, which organized by SEBMC, supported by International Alliance of Innovation Drug Research and European Association for Bio-industries and Biotechnology Industry Organization, at that time, more than 400 multinational pharmaceutical company leaders, global top level drug & medicine scientist and experts who from USA, Europe, China and Asia will join in this Forum, it will concern Bio-pharmaceutical, new drug research, innovative drug R&D outsourcing, pharmaceutical clinical research, translational medicine and personalized treatment technology, the Forum focus on new anticancer drugs, cardiovascular drugs, anti-diabetic drugs, neurodegenerative drugs, anti-infective drugs and resistance to major diseases drug innovation and clinical applications, antibody humanized technology and pharmaceutical technology invention, tumor molecular targeted drug development and targeted therapy technology, monoclonal antibody drug development and cell line development technology, Clinical Oncology Translational Medicine and individualized treatment, the forum will also explore that the Asian Pharmaceutical face the challenges of global blockbuster stage bio-pharmaceutical patents expiring peak, how to search for the production line of potential new drug development in Asia, how to control control the the new drug R&D investment and seek a reasonable balance during Drug Listing! Bring new drug development to maximize profits, to accelerate the transformation of drug R&D from the laboratory to clinical application, to search for future Asian new drug R&D trend and innovative model of win-win cooperation, to inject change drivers positive energy for the fast-growing Asian and emerging market R & D, to decode the Asian innovative drugs and translational medicine revolution, promote Asian new drug development and clinical medicine innovation. At the same time, The 6th (2013) International Bio-pharmaceutical and Biochemistry Instrument (Shanghai) Exhibition will be also held together, This exhibition will display comprehensively the Asian and international cutting-edge biomedical technology, the innovative biological products, laboratory equipment, clinical treatment and diagnostic testing equipment, diagnostic reagents and biochemical analysis equipment and other innovative products, this forum will be the most forefront event in Asian Pharmaceutical .



Further information
Scientific News
BioCision Forms MedCision
The new company will focus on technologies for the management and automation of vital clinical processes.
First New HIV Vaccine Study for Seven Years Begins
South Africa hosts historic clinical trial of experimental HIV vaccine aiming to safely prevent HIV infection.
Study to Assess Shorter-Duration Antibiotics in Children
Physicians plan a clinical trial to evaluate whether short course anti-biotics are effective at treating CAP in children.
Cancer Gene Predicts Treatment Response in Leukaemia
Study indicates the patients suffering from a lethal for of acute myeloid leukemia may live longer when receiving milder chemotherapy drugs.
Injectable Biologic Therapy Reduces Triglycerides
Study finds first-of-its-kind therapy promising for patients with high triglycerides, cholesterol.
Testing Zika Vaccine in Humans Begins
The first of five planned clinical trials to test ZPIV vaccine in humans has begun.
Combination Therapy Improved Chemoresistance in Ovarian Cancer
The study demonstrates how an existing class of targeted therapies could be used to potentiate the tumor suppression induced by cisplatin.
Gene Therapy for Blistering Skin Disease Shows Promise
Grafting genetically altered skin onto patients’ chronic wounds marks the first time skin-based gene therapy has been demonstrated to be safe and effective in humans.
Alzheimer’s Treatment Moves a Step Closer
Merck scientists have reported the discovery of verubecestat, a structurally unique, orally bioavailable small molecule that has been shown to target the most visible sign of the disease in the brain.
Lynparza Phase III Progression-Free Survival Benefit
AstraZeneca announces results from Phase III SOLO-2 trial designed to determine the efficacy of Lynparza as a monotherapy for ovarian cancer.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!